drugset / Trial / NCT02162446
68Ga-OPS202 Study for Diagnostic Imaging of GEP NET
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of this study is to assess the safety and tolerability of 68Ga-OPS202 used for the diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP NETs).
Timeline
- Start
- 2014-06
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Satoreotide trizoxetan | Diagnostic / imaging agent | — | — |